Capital City Trust’s Gilead Sciences GILD Stock Holding History

Capital City Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$439K	Buy	+3,152	New	+$441K	0.1%	91
2019 Q2	–	Sell	-4,346	Closed	-$283K	–	98
2019 Q1	$283K	Buy	4,346 +116	+3%	+$7.71K	0.12%	87
2018 Q4	$265K	Buy	4,230 +120	+3%	+$8.39K	0.12%	90
2018 Q3	$317K	Buy	4,110 +41	+1%	+$3.1K	0.13%	90
2018 Q2	$288K	Sell	4,069 -60	-1%	-$4.24K	0.12%	89
2018 Q1	$311K	Hold	4,129	–	–	0.13%	89
2017 Q4	$296	Sell	4,129 -133	-3%	-$10.1K	0.12%	93
2017 Q3	$302K	Hold	4,262	–	–	0.12%	88
2017 Q2	$302K	Buy	4,262 +418	+11%	+$27.8K	0.12%	88
2017 Q1	$261K	Buy	3,844 +535	+16%	+$37.6K	0.1%	92
2016 Q4	$237K	Buy	+3,309	New	+$246K	0.09%	97

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital City Trust's GILD Position: Q1 2026 in Review

Capital City Trust opened a new position in Gilead Sciences (GILD) in Q1 2026: 3,152 shares worth $439K. The stake represents 0.1% of the portfolio and ranks #91 among its holdings. This is a return to the name: Capital City Trust previously reported a position in GILD as recently as Q1 2019.

Capital City Trust first reported a position in GILD in Q4 2016 and has held it in 11 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Capital City Trust held 3,152 shares of Gilead Sciences worth $439K as of Q1 2026.
Gilead Sciences was a new Capital City Trust position in Q1 2026.
Gilead Sciences made up 0.1% of Capital City Trust's portfolio in Q1 2026, its #91 holding.
Capital City Trust first reported a position in Gilead Sciences in Q4 2016 and has held it in 11 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capital City Trust's 13F filing for Q1 2026, filed 1 May 2026.